Higher CD4 cell count at enrollment was significantly associated with a lower odds of mortality in unadjusted models (OR, 0.69 [95% CI, .55–.87) (Table 4), and grade ≥3 anemia with a significantly greater odds of mortality (4.86 [1.71–13.81]). This evidence concerns the gene CD4 and anemia (phenotype).